An aggrecan fragment drives osteoarthritis pain through Toll-like receptor 2
Rachel E. Miller(Northwestern University), Anne‐Marie Malfait(Rush University Medical Center), Karena Last(Royal Children's Hospital), Shingo Ishihara(Rush University Medical Center), Suzanne B. Golub(Royal Children's Hospital), Phuong Bich Tran(Rush University Medical Center), Amanda Fosang(Royal Children's Hospital), Richard J. Miller(Northwestern University)
Cited by 114
Related Papers
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
|Proceedings of the National Academy of Sciences|2000|662
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5
|Arthritis & Rheumatism|2007|403
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation
|Osteoarthritis and Cartilage|2001|324
Osteoarthritis joint pain: The cytokine connection
|Cytokine|2014|321
Osteoarthritis
|Nature Reviews Disease Primers|2025|316